Research Grant
[Cite as https://purl.org/au-research/grants/arc/LP0882596]Researchers: Dr Milena Ginic-Markovic (Chief Investigator) , Nikolai Petrovsky (Chief Investigator) , Prof Janis Matisons (Chief Investigator) , Dr Peter Cooper (Partner Investigator)
Brief description Nanotechnology-Enhanced Vaccines: New inulin bioconjugates to defeat global pandemic threats. Inulin-based adjuvants have the potential to revolutionise the vaccine arena; man's critical first line of defence against infectious disease. Any breakthrough in developing completely safe new adjuvants, will therefore be of major global significance, and will play a vital role in the maintenance of global health for decades. New and completely safe vaccine adjuvants are a vital step in the development of improved vaccine technology in the 21st century. This project addresses two National Research Priorities, Namely Promoting and Maintaining Good Health and Safeguarding Australia. On commercialization, this will then be an important Australian contribution towards protecting the nation against any future pandemic outbreaks.
Funding Amount $135,000
Funding Scheme Linkage Projects
- PURL : https://purl.org/au-research/grants/arc/LP0882596
- ARC : LP0882596